Table 1 Baseline characteristics of study participants (n = 20)
# (%) | |
|---|---|
Age, median, years (IQR) | 65 (6.0) |
Black race | 17 (85) |
Distance traveled to appointments, median miles (IQR) | 41 (60) |
SUD treatment engagement | 6 (30) |
AUDIT score1, mean (SD) | 12.4 (8.7) |
DAST score2, mean (SD) (n = 16) | 4.6 (3.5) |
SUD diagnoses3 | |
Alcohol | 16 (80) |
Cannabis | 12 (60) |
Cocaine | 10 (50) |
Opioid | 5 (25) |
Psychiatric diagnoses3 | |
Depressive disorder | 8 (40) |
Anxiety disorder | 7 (35) |
Post-traumatic stress disorder | 3 (15) |
Schizophrenia | 3 (15) |
Bipolar disorder | 2 (10) |
HCV Genotype | |
1a4 | 17 (85) |
1b | 3 (15) |
ALT, median, IU/L (IQR) | 61.5 (31.5) |
FIB-4 score, median (IQR) | 2.0 (1.0) |
HCV RNA, median, log IU/mL (IQR) | 6.21 (0.62) |